Cristina Montagna

7.2k total citations
124 papers, 4.8k citations indexed

About

Cristina Montagna is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Cristina Montagna has authored 124 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 40 papers in Genetics and 28 papers in Oncology. Recurrent topics in Cristina Montagna's work include Cancer Genomics and Diagnostics (20 papers), Genomic variations and chromosomal abnormalities (20 papers) and Genomics and Chromatin Dynamics (17 papers). Cristina Montagna is often cited by papers focused on Cancer Genomics and Diagnostics (20 papers), Genomic variations and chromosomal abnormalities (20 papers) and Genomics and Chromatin Dynamics (17 papers). Cristina Montagna collaborates with scholars based in United States, Italy and France. Cristina Montagna's co-authors include Thomas Ried, Jan Vijg, Francesca Faggioli, Paolo Vezzoni, Massimo Gadina, John M. Greally, Thérèse Lehy, Janna Blechman, Robert H. Singer and Dov Zipori and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Cristina Montagna

123 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cristina Montagna United States	36	3.0k	1.4k	811	756	505	124	4.8k
Yoshiki Murakumo Japan	38	3.3k 1.1×	1.1k 0.8×	432 0.5×	849 1.1×	367 0.7×	129	4.7k
Giuliana Salvatore Italy	36	2.2k 0.8×	2.0k 1.4×	754 0.9×	596 0.8×	459 0.9×	83	5.3k
E. Aubrey Thompson United States	42	3.3k 1.1×	1.6k 1.1×	404 0.5×	1.2k 1.6×	504 1.0×	112	5.0k
Mark Merchant United States	32	3.1k 1.0×	1.6k 1.2×	601 0.7×	591 0.8×	567 1.1×	64	4.9k
Michelle Barton United States	46	4.6k 1.5×	1.0k 0.7×	568 0.7×	1.0k 1.4×	519 1.0×	109	5.7k
Catrin Pritchard United Kingdom	36	3.9k 1.3×	1.9k 1.4×	493 0.6×	594 0.8×	558 1.1×	88	5.9k
Shiaw‐Yih Lin United States	36	4.8k 1.6×	2.4k 1.8×	589 0.7×	1.1k 1.4×	545 1.1×	78	6.3k
Kunxin Luo United States	38	5.0k 1.7×	1.2k 0.9×	386 0.5×	739 1.0×	461 0.9×	57	6.2k
Madelon M. Maurice Netherlands	40	4.6k 1.5×	1.8k 1.3×	773 1.0×	630 0.8×	1.1k 2.2×	73	6.6k
Hans van Dam Netherlands	44	4.4k 1.5×	1.6k 1.2×	733 0.9×	1.1k 1.5×	873 1.7×	77	5.9k

Countries citing papers authored by Cristina Montagna

Since Specialization

Citations

This map shows the geographic impact of Cristina Montagna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristina Montagna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristina Montagna more than expected).

Fields of papers citing papers by Cristina Montagna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cristina Montagna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristina Montagna. The network helps show where Cristina Montagna may publish in the future.

Co-authorship network of co-authors of Cristina Montagna

This figure shows the co-authorship network connecting the top 25 collaborators of Cristina Montagna. A scholar is included among the top collaborators of Cristina Montagna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cristina Montagna. Cristina Montagna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arsdale, Anne Van, Joshua Gould, Koenraad Van Doorslaer, et al.. (2024). Structure and transcription of integrated HPV DNA in vulvar carcinomas. npj Genomic Medicine. 9(1). 35–35. 1 indexed citations

Zhang, Lei, Moonsook Lee, Alexander Y. Maslov, et al.. (2023). Analyzing somatic mutations by single-cell whole-genome sequencing. Nature Protocols. 19(2). 487–516. 10 indexed citations

Galbo, Phillip M., Anne Tranberg Madsen, Yang Liu, et al.. (2023). Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma. Clinical Cancer Research. 30(4). 865–876. 40 indexed citations

Shuter, Jonathan, H. Dean Hosgood, Ryung S. Kim, et al.. (2021). Behavioral and Genetic Factors Associated with Successful Long-Term Cessation in Persons with HIV Who Smoke Cigarettes. The Journal of Smoking Cessation. 2021. 1894160–1894160. 1 indexed citations

Gressel, Gregory M., et al.. (2020). Low molecular weight serum cell-free DNA concentration is associated with clinicopathologic indices of poor prognosis in women with uterine cancer. Journal of Translational Medicine. 18(1). 4 indexed citations

Cleven, Krystal L., Kenny Ye, Rachel Zeig‐Owens, et al.. (2019). Genetic Variants Associated with FDNY WTC-Related Sarcoidosis. International Journal of Environmental Research and Public Health. 16(10). 1830–1830. 22 indexed citations

Montagna, Cristina, et al.. (2019). A novel approach to modelling transcriptional heterogeneity identifies the oncogene candidate CBX2 in invasive breast carcinoma. British Journal of Cancer. 120(7). 746–753. 26 indexed citations

Chen, Jiahao, Daqian Sun, Tihomira I. Todorova, et al.. (2018). Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level. Nature Medicine. 25(1). 103–110. 149 indexed citations

Janakiram, Murali, Jordan M. Chinai, Susan Fineberg, et al.. (2014). Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein. Clinical Cancer Research. 21(10). 2359–2366. 131 indexed citations

10.

Son, Mi‐Young, Cory Holland, Satoshi Tateishi, et al.. (2013). Two replication fork maintenance pathways fuse inverted repeats to rearrange chromosomes. Nature. 501(7468). 569–572. 36 indexed citations

11.

Arciuch, Valeria G. Antico, Marika A. Russo, Xiao-Hui Liao, et al.. (2011). Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors. Oncotarget. 2(12). 1109–1126. 65 indexed citations

12.

Oktay, Maja H., et al.. (2010). Prognostic and predictive value of 16p12.1 and 16q22.1 copy number changes in human breast cancer. Cancer Genetics and Cytogenetics. 198(1). 52–61. 12 indexed citations

13.

Yuan, Ziqiang, Joongho Shin, Andrew J. Wilson, et al.. (2009). An A13 Repeat within the 3′-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression. Cancer Research. 69(19). 7811–7818. 32 indexed citations

14.

Jhawer, Minaxi, Sanjay Goel, Andrew J. Wilson, et al.. (2008). PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab. Cancer Research. 68(6). 1953–1961. 370 indexed citations

15.

Triplett, Aleata A., Cristina Montagna, & Kay‐Uwe Wagner. (2008). A Mammary-Specific, Long-range Deletion on Mouse Chromosome 11 Accelerates Brca1-Associated Mammary Tumorigenesis. Neoplasia. 10(12). 1325–IN3. 10 indexed citations

16.

Nagata, Koh‐ichi, et al.. (2007). Differential expression of Septin 9 isoforms in cells sensitive and resistant to microtubule stabilizing drugs.. Cancer Research. 67. 1981–1981. 1 indexed citations

17.

Khulan, Batbayar, Reid F. Thompson, Kenny Ye, et al.. (2006). Comparative isoschizomer profiling of cytosine methylation: The HELP assay. Genome Research. 16(8). 1046–1055. 287 indexed citations

18.

Yakushiji, Hiroyuki, et al.. (2005). Atm Heterozygosity Cooperates with Loss of Brca1 to Increase the Severity of Mammary Gland Cancer and Reduce Ductal Branching. Cancer Research. 65(19). 8736–8746. 20 indexed citations

19.

Montagna, Cristina, Eran R. Andrechek, Hesed Padilla‐Nash, William J. Muller, & Thomas Ried. (2002). Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu. Oncogene. 21(6). 890–898. 78 indexed citations

20.

Sacco, Maria Grazia, Laura Gribaldo, Ottavia Barbieri, et al.. (1998). Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice. Breast Cancer Research and Treatment. 47(2). 171–180. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact